{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:59:55Z","timestamp":1789171195480,"version":"build-2803163510"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03837-2","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:09:04Z","timestamp":1736302144000},"page":"2838-2851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical implications of epithelial-to-mesenchymal transition in cancers which potentially spread to peritoneum"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2862-6788","authenticated-orcid":false,"given":"Ludovico","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giosu\u00e8 Giordano","family":"Incognito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila","family":"Incognito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Nibid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Taffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Marrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"3837_CR1","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.humpath.2013.04.009","volume":"44","author":"C Mirantes","year":"2013","unstructured":"Mirantes C, Espinosa I, Ferrer I, Dolcet X, Prat J, Matias-Guiu X. Epithelial-to-mesenchymal transition and stem cells in endometrial cancer. Hum Pathol. 2013;44:1973\u201381.","journal-title":"Hum Pathol"},{"key":"3837_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","volume":"101","author":"M Iwatsuki","year":"2010","unstructured":"Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, et al. Epithelial\u2013mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101:293\u20139.","journal-title":"Cancer Sci"},{"key":"3837_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3837_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3837_CR5","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420\u20138.","journal-title":"J Clin Invest"},{"key":"3837_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.humpath.2011.07.003","volume":"43","author":"HS Ryu","year":"2012","unstructured":"Ryu HS, Park DJ, Kim HH, Kim WH, Lee HS. Combination of epithelial-mesenchymal transition and cancer stem cell\u2013like phenotypes has independent prognostic value in gastric cancer. Hum Pathol. 2012;43:520\u20138.","journal-title":"Hum Pathol"},{"key":"3837_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/modpathol.2011.59","volume":"24","author":"CO Sung","year":"2011","unstructured":"Sung CO, Park CK, Kim SH. Classification of epithelial\u2013mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis. Mod Pathol. 2011;24:1060\u20138.","journal-title":"Mod Pathol"},{"key":"3837_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3837_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/792182","volume":"2015","author":"J Pasquier","year":"2015","unstructured":"Pasquier J, Abu-Kaoud N, Al Thani H, Rafii A. Epithelial to mesenchymal transition in a clinical perspective. J Oncol. 2015;2015:1\u201310.","journal-title":"J Oncol"},{"key":"3837_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-020-01178-9","volume":"124","author":"SV Vasaikar","year":"2021","unstructured":"Vasaikar SV, Deshmukh AP, den Hollander P, Addanki S, Kuburich NA, Kudaravalli S, et al. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures. Br J Cancer. 2021;124:259\u201369.","journal-title":"Br J Cancer"},{"key":"3837_CR11","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/cancers14194961","volume":"14","author":"S Russi","year":"2022","unstructured":"Russi S, Marano L, Laurino S, Calice G, Scala D, Marino G, et al. Gene regulatory network characterization of gastric cancer\u2019s histological subtypes: distinctive biological and clinically relevant master regulators. Cancers (Basel). 2022;14:4961.","journal-title":"Cancers (Basel)"},{"key":"3837_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"The Cancer Genome Atlas Research Network","year":"2014","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"3837_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449\u201356.","journal-title":"Nat Med"},{"key":"3837_CR14","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41467-018-04179-8","volume":"9","author":"SC Oh","year":"2018","unstructured":"Oh SC, Sohn BH, Cheong JH, Kim S-B, Lee JE, Park KC, et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018;9:1777.","journal-title":"Nat Commun"},{"key":"3837_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10120-021-01242-0","volume":"25","author":"K Furukawa","year":"2022","unstructured":"Furukawa K, Hatakeyama K, Terashima M, Nagashima T, Urakami K, Ohshima K, et al. Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE. Gastric Cancer. 2022;25:138\u201348.","journal-title":"Gastric Cancer"},{"key":"3837_CR16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/SLA.0000000000005648","volume":"276","author":"M Bencivenga","year":"2022","unstructured":"Bencivenga M, Simbolo M, Ciaparrone C, Vicentini C, Torroni L, Piredda ML, et al. Poorly cohesive gastric cancers showing the transcriptomic hallmarks of epithelial-mesenchymal transition behave aggressively. Ann Surg. 2022;276:822\u20139.","journal-title":"Ann Surg"},{"key":"3837_CR17","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.3390\/cancers14246023","volume":"14","author":"D Marrelli","year":"2022","unstructured":"Marrelli D, Marano L, Ambrosio MR, Carbone L, Spagnoli L, Petrioli R, et al. Immunohistochemical markers of the epithelial-to-mesenchymal transition (EMT) are related to extensive lymph nodal spread, peritoneal dissemination, and poor prognosis in the microsatellite-stable diffuse histotype of gastric cancer. Cancers (Basel). 2022;14:6023.","journal-title":"Cancers (Basel)"},{"key":"3837_CR18","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.3390\/ijms241914815","volume":"24","author":"J Lu","year":"2023","unstructured":"Lu J, Kornmann M, Traub B. Role of epithelial to mesenchymal transition in colorectal cancer. Int J Mol Sci. 2023;24:14815.","journal-title":"Int J Mol Sci"},{"key":"3837_CR19","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"3837_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.suronc.2012.08.003","volume":"21","author":"A Bhangu","year":"2012","unstructured":"Bhangu A, Wood G, Mirnezami A, Darzi A, Tekkis P, Goldin R. Epithelial mesenchymal transition in colorectal cancer: seminal role in promoting disease progression and resistance to neoadjuvant therapy. Surg Oncol. 2012;21:316\u201323.","journal-title":"Surg Oncol"},{"key":"3837_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","volume":"30","author":"A Lugli","year":"2017","unstructured":"Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, et al. Recommendations for reporting tumor budding in colorectal cancer based on the international tumor budding consensus conference (ITBCC) 2016. Mod Pathol. 2017;30:1299\u2013311.","journal-title":"Mod Pathol"},{"key":"3837_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.18632\/oncotarget.199","volume":"1","author":"I Zlobec","year":"2010","unstructured":"Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2010;1:651\u201361.","journal-title":"Oncotarget"},{"key":"3837_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clcc.2016.06.002","volume":"16","author":"V Barresi","year":"2017","unstructured":"Barresi V, Reggiani Bonetti L, Ieni A, Caruso RA, Tuccari G. Poorly differentiated clusters: clinical impact in colorectal cancer. Clin Colorectal Cancer. 2017;16:9\u201315.","journal-title":"Clin Colorectal Cancer"},{"key":"3837_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4251\/wjgo.v10.i7.145","volume":"10","author":"M Chand","year":"2018","unstructured":"Chand M, Keller DS, Mirnezami R, Bullock M, Bhangu A, Moran B, et al. Novel biomarkers for patient stratification in colorectal cancer: a review of definitions, emerging concepts, and data. World J Gastrointest Oncol. 2018;10:145\u201358.","journal-title":"World J Gastrointest Oncol"},{"key":"3837_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/cancers9090122","volume":"9","author":"N Gaianigo","year":"2017","unstructured":"Gaianigo N, Melisi D, Carbone C. EMT and treatment resistance in pancreatic cancer. Cancers (Basel). 2017;9:122.","journal-title":"Cancers (Basel)"},{"key":"3837_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349\u201361.","journal-title":"Cell"},{"key":"3837_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6490349","volume":"2017","author":"S Wang","year":"2017","unstructured":"Wang S, Huang S, Sun YL. Epithelial-mesenchymal transition in pancreatic cancer: a review. Biomed Res Int. 2017;2017:1\u201310.","journal-title":"Biomed Res Int"},{"key":"3837_CR28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17:500\u20133.","journal-title":"Nat Med"},{"key":"3837_CR29","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","volume":"69","author":"T Arumugam","year":"2009","unstructured":"Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009;69:5820\u20138.","journal-title":"Cancer Res"},{"key":"3837_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.surg.2013.05.004","volume":"154","author":"S Yamada","year":"2013","unstructured":"Yamada S, Fuchs BC, Fujii T, Shimoyama Y, Sugimoto H, Nomoto S, et al. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery. 2013;154:946\u201354.","journal-title":"Surgery"},{"key":"3837_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501:328\u201337.","journal-title":"Nature"},{"key":"3837_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"3837_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.canlet.2014.09.021","volume":"356","author":"R Qureshi","year":"2015","unstructured":"Qureshi R, Arora H, Rizvi MA. EMT in cervical cancer: its role in tumour progression and response to therapy. Cancer Lett. 2015;356:321\u201331.","journal-title":"Cancer Lett"},{"key":"3837_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034071","volume":"7","author":"JC Cheng","year":"2012","unstructured":"Cheng JC, Auersperg N, Leung PCK. EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells? PLoS ONE. 2012;7: e34071.","journal-title":"PLoS ONE"},{"key":"3837_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","volume":"26","author":"S Pradeep","year":"2014","unstructured":"Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T, et al. Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread. Cancer Cell. 2014;26:77\u201391.","journal-title":"Cancer Cell"},{"key":"3837_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177:1053\u201364.","journal-title":"Am J Pathol"},{"key":"3837_CR37","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1242\/jcs.00389","volume":"116","author":"J Ikenouchi","year":"2003","unstructured":"Ikenouchi J, Matsuda M, Furuse M, Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition:direct repression of the gene expression of claudins\/occludin by Snail. J Cell Sci. 2003;116:1959\u201367.","journal-title":"J Cell Sci"},{"key":"3837_CR38","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1158\/1078-0432.CCR-08-0234","volume":"14","author":"MY Lee","year":"2008","unstructured":"Lee MY, Chou CY, Tang MJ, Shen MR. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res. 2008;14:4743\u201350.","journal-title":"Clin Cancer Res"},{"key":"3837_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3892\/ol.2011.512","volume":"3","author":"YM Cheng","year":"2012","unstructured":"Cheng YM, Chou CY, Hsu YC, Chen MJ, Wing LYC. The role of human papillomavirus type 16 E6\/E7 oncoproteins in cervical epithelial-mesenchymal transition and carcinogenesis. Oncol Lett. 2012;3:667\u201371.","journal-title":"Oncol Lett"},{"key":"3837_CR40","doi-asserted-by":"publisher","first-page":"15610","DOI":"10.18632\/oncotarget.3639","volume":"6","author":"M Zhao","year":"2015","unstructured":"Zhao M, Fang W, Wang Y, Guo S, Shu L, Wang L, et al. Enolase-1 is a therapeutic target in endometrial carcinoma. Oncotarget. 2015;6:15610\u201327.","journal-title":"Oncotarget"},{"key":"3837_CR41","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.18632\/oncotarget.2157","volume":"5","author":"Y Konno","year":"2014","unstructured":"Konno Y, Dong P, Xiong Y, Suzuki F, Lu J, Cai M, et al. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget. 2014;5:6049\u201362.","journal-title":"Oncotarget"},{"key":"3837_CR42","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1210\/me.2007-0512","volume":"22","author":"SH Park","year":"2008","unstructured":"Park SH, Cheung LWT, Wong AST, Leung PCK. Estrogen regulates snail and slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor \u03b1. Mol Endocrinol. 2008;22:2085\u201398.","journal-title":"Mol Endocrinol"},{"key":"3837_CR43","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1097\/IGC.0000000000000279","volume":"24","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhang J, Zhu Y, Zhang Z, Sun H, Feng Y. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K\/Akt-snail signaling pathway. Int J Gynecol Cancer. 2014;24:1564\u201374.","journal-title":"Int J Gynecol Cancer"},{"key":"3837_CR44","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.37.EP1151","author":"SY Jeon","year":"2015","unstructured":"Jeon SY, Choi KC. Progesterone is a potent substance which inhibits the migration of ovarian cancer cells by reducing epithelial-mesenchymal transition via progesterone receptor-dependent pathway. Endocr Abstr. 2015. https:\/\/doi.org\/10.1530\/endoabs.37.EP1151.","journal-title":"Endocr Abstr"},{"key":"3837_CR45","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-12-3039","volume":"19","author":"E Wik","year":"2013","unstructured":"Wik E, R\u00e6der MB, Krakstad C, Trovik J, Birkeland E, Hoivik EA, et al. Lack of estrogen receptor-\u03b1 is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. Clin Cancer Res. 2013;19:1094\u2013105.","journal-title":"Clin Cancer Res"},{"key":"3837_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","volume":"102","author":"Y Wu","year":"2010","unstructured":"Wu Y, Zhou BP. TNF-\u03b1\/NF-\u03baB\/snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102:639\u201344.","journal-title":"Br J Cancer"},{"key":"3837_CR47","first-page":"226","volume":"17","author":"GG Incognito","year":"2023","unstructured":"Incognito GG, Di Guardo F, Gulino FA, Genovese F, Benvenuto D, Lello C, et al. Interleukin-6 as a useful predictor of endometriosis-associated infertility: a systematic review. Int J Fertil Steril. 2023;17:226\u201330.","journal-title":"Int J Fertil Steril"},{"key":"3837_CR48","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1073\/pnas.0802047105","volume":"105","author":"C Sahlgren","year":"2008","unstructured":"Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci. 2008;105:6392\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"3837_CR49","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3892\/or.2014.3448","volume":"32","author":"Y Wang","year":"2014","unstructured":"Wang Y, Ma J, Shen H, Wang C, Sun Y, Howell SB, et al. Reactive oxygen species promote ovarian cancer progression via the HIF-1\u03b1\/LOX\/E-cadherin pathway. Oncol Rep. 2014;32:2150\u20138.","journal-title":"Oncol Rep"},{"key":"3837_CR50","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/jcb.23199","volume":"112","author":"A Latifi","year":"2011","unstructured":"Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, et al. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. J Cell Biochem. 2011;112:2850\u201364.","journal-title":"J Cell Biochem"},{"key":"3837_CR51","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.molonc.2016.04.002","volume":"10","author":"C Blassl","year":"2016","unstructured":"Blassl C, Kuhlmann JD, Webers A, Wimberger P, Fehm T, Neubauer H. Gene expression profiling of single circulating tumor cells in ovarian cancer \u2013 Establishment of a multi-marker gene panel. Mol Oncol. 2016;10:1030\u201342.","journal-title":"Mol Oncol"},{"key":"3837_CR52","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14:818\u201329.","journal-title":"Dev Cell"},{"key":"3837_CR53","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1158\/1541-7786.MCR-10-0568","volume":"9","author":"D Yao","year":"2011","unstructured":"Yao D, Dai C, Peng S. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res. 2011;9:1608\u201320.","journal-title":"Mol Cancer Res"},{"key":"3837_CR54","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/1878-0261.12083","volume":"11","author":"MK Jolly","year":"2017","unstructured":"Jolly MK, Ware KE, Gilja S, Somarelli JA, Levine H. EMT and MET: necessary or permissive for metastasis? Mol Oncol. 2017;11:755\u201369.","journal-title":"Mol Oncol"},{"key":"3837_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100899","volume":"14","author":"J Wu","year":"2021","unstructured":"Wu J, Jiang J, Chen B, Wang K, Tang Y, Liang X. Plasticity of cancer cell invasion: patterns and mechanisms. Transl Oncol. 2021;14: 100899.","journal-title":"Transl Oncol"},{"key":"3837_CR56","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ajpath.2011.03.035","volume":"179","author":"P Martin","year":"2011","unstructured":"Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, et al. Prostate epithelial Pten\/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am J Pathol. 2011;179:422\u201335.","journal-title":"Am J Pathol"},{"key":"3837_CR57","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/cas.15244","volume":"113","author":"J Yamasaki","year":"2022","unstructured":"Yamasaki J, Hirata Y, Otsuki Y, Suina K, Saito Y, Masuda K, et al. MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer. Cancer Sci. 2022;113:916\u201325.","journal-title":"Cancer Sci"},{"key":"3837_CR58","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927\u201339.","journal-title":"Cell"},{"key":"3837_CR59","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/1541-7786.MCR-20-0532","volume":"19","author":"JB Addison","year":"2021","unstructured":"Addison JB, Voronkova MA, Fugett JH, Lin CC, Linville NC, Trinh B, et al. Functional hierarchy and cooperation of EMT master transcription factors in breast cancer metastasis. Mol Cancer Res. 2021;19:784\u201398.","journal-title":"Mol Cancer Res"},{"key":"3837_CR60","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs AM, Mitschke J, Losada ML, Schmalhofer O, Boerries M, Busch H, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017;19:518\u201329.","journal-title":"Nat Cell Biol"},{"key":"3837_CR61","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670\u201391.","journal-title":"Cell"},{"key":"3837_CR62","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trend Cell Biol. 2019;29:212\u201326.","journal-title":"Trend Cell Biol"},{"key":"3837_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.61","author":"M Saxena","year":"2011","unstructured":"Saxena M, Stephens MA, Pathak H, Rangarajan A. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis. 2011. https:\/\/doi.org\/10.1038\/cddis.2011.61.","journal-title":"Cell Death Dis"},{"key":"3837_CR64","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3892\/mmr.2017.6960","volume":"16","author":"T Feng","year":"2017","unstructured":"Feng T, Wang Y, Lang Y, Zhang Y. KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance. Mol Med Rep. 2017;16:3573\u201380.","journal-title":"Mol Med Rep"},{"key":"3837_CR65","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.biopha.2018.07.059","volume":"106","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Huang S, Guo Y, Li L. MiR-1294 confers cisplatin resistance in ovarian cancer cells by targeting IGF1R. Biomed Pharmacother. 2018;106:1357\u201363.","journal-title":"Biomed Pharmacother"},{"key":"3837_CR66","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"3837_CR67","doi-asserted-by":"publisher","first-page":"15093","DOI":"10.18632\/oncotarget.7618","volume":"7","author":"SKD Dwivedi","year":"2016","unstructured":"Dwivedi SKD, Mustafi SB, Mangala LS, Jiang D, Pradeep S, Rodriguez-Aguayo C, et al. Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 2016;7:15093\u2013104.","journal-title":"Oncotarget"},{"key":"3837_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/srep46312","author":"C Samardzija","year":"2017","unstructured":"Samardzija C, Greening DW, Escalona R, Chen M, Bilandzic M, Luwor R, et al. Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/srep46312.","journal-title":"Sci Rep"},{"key":"3837_CR69","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1002\/jcp.27369","volume":"234","author":"M Zhang","year":"2019","unstructured":"Zhang M, Cong Q, Zhang XY, Zhang MX, Lu YY, Xu CJ. Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation. J Cell Physiol. 2019;234:6361\u201370.","journal-title":"J Cell Physiol"},{"key":"3837_CR70","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013;19:279\u201390.","journal-title":"Clin Cancer Res"},{"key":"3837_CR71","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 2017;546:431\u20135.","journal-title":"Nature"},{"key":"3837_CR72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-4598-12-24","volume":"12","author":"K Abubaker","year":"2013","unstructured":"Abubaker K, Latifi A, Luwor R, Nazaretian S, Zhu H, Quinn MA, et al. Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer. 2013;12:24.","journal-title":"Mol Cancer"},{"key":"3837_CR73","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrd4253","volume":"13","author":"DR Pattabiraman","year":"2014","unstructured":"Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells\u2014what challenges do they pose? Nat Rev Drug Discov. 2014;13:497\u2013512.","journal-title":"Nat Rev Drug Discov"},{"key":"3837_CR74","doi-asserted-by":"publisher","first-page":"76881","DOI":"10.18632\/oncotarget.20173","volume":"8","author":"K Alwosaibai","year":"2017","unstructured":"Alwosaibai K, Abedini A, Al-Hujaily EM, Tang Y, Garson K, Collins O, et al. PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state. Oncotarget. 2017;8:76881\u201397.","journal-title":"Oncotarget"},{"key":"3837_CR75","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10106","author":"G Mor","year":"2013","unstructured":"Mor G, Alvero A. The duplicitous origin of ovarian cancer. Rambam Maimonides Med J. 2013. https:\/\/doi.org\/10.5041\/RMMJ.10106.","journal-title":"Rambam Maimonides Med J"},{"key":"3837_CR76","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.15252\/emmm.201404208","volume":"6","author":"TZ Tan","year":"2014","unstructured":"Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY, et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014;6:1279\u201393.","journal-title":"EMBO Mol Med"},{"key":"3837_CR77","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-15-1434","volume":"22","author":"Y Lou","year":"2016","unstructured":"Lou Y, Diao L, Cuentas ERP, Denning WL, Chen L, Fan YH, et al. Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma. Clin Cancer Res. 2016;22:3630\u201342.","journal-title":"Clin Cancer Res"},{"key":"3837_CR78","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/1878-0261.12093","volume":"11","author":"S Terry","year":"2017","unstructured":"Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery JP, et al. New insights into the role of EMT in tumor immune escape. Mol Oncol Mol Oncol. 2017;11:824\u201346.","journal-title":"Mol Oncol Mol Oncol"},{"key":"3837_CR79","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10585-018-9906-x","volume":"35","author":"AD Redfern","year":"2018","unstructured":"Redfern AD, Spalding LJ, Thompson EW. The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome. Clin Exp Metastas. 2018;35:285\u2013308.","journal-title":"Clin Exp Metastas"},{"key":"3837_CR80","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000512218","volume":"211","author":"S Jonckheere","year":"2022","unstructured":"Jonckheere S, Adams J, De Groote D, Campbell K, Berx G, Goossens S. Epithelial-mesenchymal transition (EMT) as a therapeutic target. Cell Tissues Organ. 2022;211:157\u201382.","journal-title":"Cell Tissues Organ"},{"key":"3837_CR81","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2147\/OTT.S161109","volume":"11","author":"L Xia","year":"2018","unstructured":"Xia L, Tan S, Zhou Y, Lin J, Wang H, Oyang L, et al. Role of the NF\u03baB-signaling pathway in cancer. Onco Target Ther. 2018;11:2063\u201373.","journal-title":"Onco Target Ther"},{"key":"3837_CR82","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3680","author":"DR Pattabiraman","year":"2016","unstructured":"Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016. https:\/\/doi.org\/10.1126\/science.aad3680.","journal-title":"Science"},{"key":"3837_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1059-5","author":"L Zhang","year":"2019","unstructured":"Zhang L, Liao Y, Tang L. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J Exp Clin Cancer Res. 2019. https:\/\/doi.org\/10.1186\/s13046-019-1059-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"3837_CR84","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/2159-8290.CD-20-0603","volume":"11","author":"A Dongre","year":"2021","unstructured":"Dongre A, Rashidian M, Eaton EN, Reinhardt F, Thiru P, Zagorulya M, et al. Direct and indirect regulators of epithelial-mesenchymal transition-mediated immunosuppression in breast carcinomas. Cancer Discov. 2021;11:1286\u2013305.","journal-title":"Cancer Discov"},{"key":"3837_CR85","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/sj.bjc.6601685","volume":"90","author":"A Miyoshi","year":"2004","unstructured":"Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer. 2004;90:1265\u201373.","journal-title":"Br J Cancer"},{"key":"3837_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1161-8","author":"M Shen","year":"2019","unstructured":"Shen M, Xu Z, Xu W, Jiang K, Zhang F, Ding Q, et al. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK\/STAT3\/PD-L1 pathway. J Exp Clin Cancer Res. 2019. https:\/\/doi.org\/10.1186\/s13046-019-1161-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"3837_CR87","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature15748","volume":"527","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong STC, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527:472\u20136.","journal-title":"Nature"},{"key":"3837_CR88","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29:4741\u201351.","journal-title":"Oncogene"},{"key":"3837_CR89","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","volume":"139","author":"MY Kim","year":"2009","unstructured":"Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XHF, Norton L, et al. Tumor self-seeding by circulating cancer cells. Cell. 2009;139:1315\u201326.","journal-title":"Cell"},{"key":"3837_CR90","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.cell.2011.11.016","volume":"147","author":"P Friedl","year":"2011","unstructured":"Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell. 2011;147:992\u20131009.","journal-title":"Cell"},{"key":"3837_CR91","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pharmthera.2017.08.009","volume":"182","author":"M Singh","year":"2018","unstructured":"Singh M, Yelle N, Venugopal C, Singh SK. EMT: mechanisms and therapeutic implications. Pharmacol Ther. 2018;182:80\u201394.","journal-title":"Pharmacol Ther"},{"key":"3837_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-024-01865-9","author":"MH Emile","year":"2024","unstructured":"Emile MH, Emile SH, El-Karef AA, Ebrahim MA, Mohammed IE, Ibrahim DA. Association between the expression of epithelial\u2013mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer. Updates Surg. 2024. https:\/\/doi.org\/10.1007\/s13304-024-01865-9.","journal-title":"Updates Surg"},{"key":"3837_CR93","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1757-2215-7-76","volume":"7","author":"M Takai","year":"2014","unstructured":"Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, et al. The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer. J Ovarian Res. 2014;7:76.","journal-title":"J Ovarian Res"},{"key":"3837_CR94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4161\/cbt.22625","volume":"14","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Terai Y, Kawaguchi H, Fujiwara S, Yoo S, Tsunetoh S, et al. Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer. Cancer Biol Ther. 2013;14:13\u20139.","journal-title":"Cancer Biol Ther"},{"key":"3837_CR95","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/cam4.751","volume":"5","author":"L Rojas-Puentes","year":"2016","unstructured":"Rojas-Puentes L, Cardona AF, Carranza H, Vargas C, Jaramillo LF, Zea D, et al. Epithelial\u2013mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy. Cancer Med. 2016;5:1989\u201399.","journal-title":"Cancer Med"},{"key":"3837_CR96","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D. Novel therapeutic strategies: targeting epithelial\u2013mesenchymal transition in colorectal cancer. Lancet Oncol. 2021;22:e358\u201368.","journal-title":"Lancet Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03837-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03837-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03837-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T16:02:16Z","timestamp":1750348936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03837-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":96,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3837"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03837-2","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}